Advertisements

First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration

First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration.....»»

Category: press-releasesSource: businesswireindiaMar 15th, 2017

Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus

Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus.....»»

Category: press-releasesSource: businesswireindiaJun 14th, 2017

Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma

Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma.....»»

Category: press-releasesSource: businesswireindiaJun 8th, 2017

Updated Data from Phase 1 Trial of Oral IDHIFA® (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation

Updated Data from Phase 1 Trial of Oral IDHIFA® (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation.....»»

Category: press-releasesSource: businesswireindiaJun 7th, 2017

Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA Clinical Trial Data in Journal of Clinical Oncology

Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA Clinical Trial Data in Journal of Clinical Oncology.....»»

Category: press-releasesSource: businesswireindiaMay 8th, 2017

Milacron Marks Another Milestone in India – Milacron Delivers the 12,501st Indian Made Injection Molding Machine

Milacron Marks Another Milestone in India – Milacron Delivers the 12,501st Indian Made Injection Molding Machine.....»»

Category: press-releasesSource: businesswireindiaApr 19th, 2017

Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate

Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate.....»»

Category: press-releasesSource: businesswireindiaApr 5th, 2017

Indian Art Ideas Accomplished a Major Landmark, Congregation of More than 1000 Artists

Indian Art Ideas Accomplished a Major Landmark, Congregation of More than 1000 Artists.....»»

Category: press-releasesSource: businesswireindiaApr 5th, 2017

When you Buy a Home at Castle Rock, you Step into a Community of Luxury Housing: Dr Niranjan Hiranandani

When you Buy a Home at Castle Rock, you Step into a Community of Luxury Housing: Dr Niranjan Hiranandani.....»»

Category: press-releasesSource: businesswireindiaMar 30th, 2017

SHOPX Achieves 2.7 Cr GMV in a Single Day

SHOPX Achieves 2.7 Cr GMV in a Single Day.....»»

Category: press-releasesSource: businesswireindiaMar 27th, 2017

Verizon and SES Trial Ultra HD Delivery

Verizon and SES Trial Ultra HD Delivery.....»»

Category: press-releasesSource: businesswireindiaMar 27th, 2017

Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases

Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases.....»»

Category: press-releasesSource: businesswireindiaMar 20th, 2017

Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation

Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation.....»»

Category: press-releasesSource: businesswireindiaMar 20th, 2017

Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy

Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy.....»»

Category: press-releasesSource: businesswireindiaMar 5th, 2017

South Korean Intellectual Property Trial and Appeal Board Upholds Validity of 3M Korean Patent

South Korean Intellectual Property Trial and Appeal Board Upholds Validity of 3M Korean Patent.....»»

Category: press-releasesSource: businesswireindiaFeb 27th, 2017

Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung

Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung.....»»

Category: press-releasesSource: businesswireindiaFeb 11th, 2017

CellProthera Raises 8.3 Million Euros

CellProthera Raises 8.3 Million Euros.....»»

Category: press-releasesSource: businesswireindiaFeb 3rd, 2017

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150.....»»

Category: press-releasesSource: businesswireindiaJan 17th, 2017

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150.....»»

Category: press-releasesSource: businesswireindiaJan 17th, 2017

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye.....»»

Category: press-releasesSource: prnewswireJan 4th, 2017

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye.....»»

Category: press-releasesSource: prnewswireJan 4th, 2017